X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Study identifies prostate cancer subgroup likely to benefit from adjuvant radiotherapy

Doctor and nurse stand in front of computer screen reviewing a recent MRI scan

A recent study published in the Journal of Clinical Oncology identified a subgroup of men with prostate cancer and adverse pathology who may benefit from adjuvant radiation therapy.1

Specifically, adjuvant radiation therapy was associated with a significant reduction in all-cause mortality (ACM) in patients with positive pelvic lymph nodes or a prostatectomy Gleason score of 8 to 10 with disease extending beyond the prostate.

Read the full article here. 

source: Hayley Virgil - Urology Times